Cargando…

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma

Due to the extremely intrinsic heterogeneity among glioma patients, the outcomes of these patients are tremendously different. Therefore, the exploitation of novel biomarker classification of glioma is vitally important for deep insight into the essence and predicting the prognosis of glioma. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanming, Wang, Ye, He, Qiheng, Wang, Wen, Zhang, Tan, Wang, Zhongyong, Dong, Jun, Lan, Qing, Zhao, Jizong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267133/ https://www.ncbi.nlm.nih.gov/pubmed/34121368 http://dx.doi.org/10.1002/cam4.4016

Ejemplares similares

A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma
por: Wang, Hua, et al.
Publicado: (2023)

An in silico approach to the identification of diagnostic and prognostic markers in low-grade gliomas
por: Özbek, Melih, et al.
Publicado: (2023)

CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma
por: Wang, Dengfeng, et al.
Publicado: (2022)

Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study
por: Liu, Jieting, et al.
Publicado: (2021)

Significance of TP53 mutation in bladder cancer disease progression and drug selection
por: Wu, Guang, et al.
Publicado: (2019)

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma
por: Zhu, Jin, et al.
Publicado: (2019)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas
por: Li, Shenglun, et al.
Publicado: (2023)

Expression patterns and the prognostic value of the EMILIN/Multimerin family members in low-grade glioma
por: Zhao, Yonghui, et al.
Publicado: (2020)

Expression profiles and prognostic significance of WNT family members in glioma via bioinformatic analysis
por: Xu, Anqi, et al.
Publicado: (2020)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
por: Ji, Qiankun, et al.
Publicado: (2022)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

PPP1R81 correlates with the survival and cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
por: Wager, M, et al.
Publicado: (2006)

ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
por: Shi, Mingguang, et al.
Publicado: (2016)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
por: Xu, Yang, et al.
Publicado: (2019)

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer
por: Zhang, Mingdi, et al.
Publicado: (2020)

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer
por: Liu, Limei, et al.
Publicado: (2020)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma
por: Ji, Baowei, et al.
Publicado: (2020)

NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas
por: Sun, Huaiyu, et al.
Publicado: (2020)

Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma
por: Wiestler, Benedikt, et al.
Publicado: (2016)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
por: Kern, Maike, et al.
Publicado: (2020)

Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma
por: Zhang, Bo, et al.
Publicado: (2021)

Automated Machine-Learning Framework Integrating Histopathological and Radiological Information for Predicting IDH1 Mutation Status in Glioma
por: Wang, Dingqian, et al.
Publicado: (2021)

Clinical and molecular assessment of an onco‐immune signature with prognostic significance in patients with colorectal cancer
por: Ahluwalia, Pankaj, et al.
Publicado: (2022)

The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis
por: Min, Zhao, et al.
Publicado: (2021)

The prognostic significance of KLRB1 and its further association with immune cells in breast cancer
por: Xu, Ning, et al.
Publicado: (2023)

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
por: Fan, Demin, et al.
Publicado: (2020)

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data
por: He, Yunan, et al.
Publicado: (2020)

Overexpression of RAB34 associates with tumor aggressiveness and immune infiltration in glioma
por: Hou, Peng, et al.
Publicado: (2022)

An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma
por: Liu, Danqi, et al.
Publicado: (2020)

DeephageTP: a convolutional neural network framework for identifying phage-specific proteins from metagenomic sequencing data
por: Chu, Yunmeng, et al.
Publicado: (2022)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
por: Tian, Lei, et al.
Publicado: (2021)

TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
por: Li, Jia, et al.
Publicado: (2021)

High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration
por: Wang, Hai yue, et al.
Publicado: (2023)

Prognostic impact of a lymphocyte activation-associated gene signature in GBM based on transcriptome analysis
por: Lan, Yujia, et al.
Publicado: (2021)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration
por: Li, Shoubin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4nnac7fo66nonbt4qp16vvpbmm